Immunic, Inc. Share Price
NASDAQ: IMUX | Mid CapImmunic, Inc. Stock Performance
Open $14.74 | Prev. Close $14.39 | Circuit Range N/A |
Day Range $14.47 - $15.42 | Year Range $0.51 - $15.78 | Volume 2,640 |
Average Traded $15.01 |
Immunic, Inc. Share Price Today
As of 10 August 2026, Immunic, Inc.'s share price is $14.28. The stock opened at $14.74, compared to its previous close of $14.39. During today's trading session, Immunic, Inc.'s share price traded between $14.47 and $15.42, with an average price of $14.95. Over the past 52 weeks, the stock has recorded a high of $15.78 and a low of $0.51. In terms of performance, Immunic, Inc.'s share price has risen by 1313.86% over the last six months and is up 1641.46% on a year-on-year basis.
Immunic, Inc. Share Price Chart
Immunic, Inc. Stock Fundamentals & Key Indicators
Market Cap $2.22B | PE Ratio (TTM) -23.03 | Dividend Yield N/A |
EPS (TTM) $-0.62 | Revenue (TTM) N/A | Return On Equity (TTM) 1456.20% |
Profit Margin N/A | Debt to Equity -4.59 | Quarterly Earnings Growth YoY -4.97% |
Immunic, Inc. Quarterly Profit & Loss
All figures in USD
Immunic, Inc. Annual Profit & Loss
All figures in USD
About Immunic, Inc.
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.
Immunic, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $13.91 | $14.44 | +3.18% |
Jul 2026 | $15.12 | $13.99 | -9.27% |
Jun 2026 | $15.21 | $15.42 | +2.94% |
May 2026 | $9.65 | $14.98 | +56.04% |
Apr 2026 | $1.14 | $9.60 | +768.78% |
Mar 2026 | $0.99 | $1.10 | +9.41% |
Feb 2026 | $0.62 | $1.01 | +63.17% |
Jan 2026 | $0.55 | $0.62 | +16.14% |
Dec 2025 | $0.71 | $0.53 | -25.14% |
Nov 2025 | $0.77 | $0.71 | -8.25% |
Oct 2025 | $0.89 | $0.78 | -12.51% |
Sep 2025 | $0.83 | $0.89 | +8.17% |
IMUX Share Price FAQs
What is Immunic, Inc. share price today?
What is the 52 week high and 52 week low of Immunic, Inc. stock?
What is IMUX's market capitalisation today?
What is IMUX's net income for the last quarter?
What is the 5 year returns of IMUX?
What is the high & low stock price of IMUX today?
Can I buy IMUX shares in India?